AgingResearch.NewsJoin free

BMI standard-deviation score

Biomarker

1 paper1 finding

  • Human trial1

Interventions

1

Liraglutide

downin humans1

1 study

  1. Liraglutide decreases BMI standard-deviation score in humans (estimated difference, -0.22 (95% CI, -0.37 to -0.08)).

    “Liraglutide was superior to placebo with regard to the change from baseline in the BMI standard-deviation score at week 56 (estimated difference, -0.22; 95% confidence interval [CI], -0.37 to -0.08; P = 0.002).”

    Human trialadolescents with obesitysubcutaneous3.0 mg56 weeks

    A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

    The New England journal of medicine31 Mar 2020

More on Liraglutide

Latest

Related